Category: Stryker Corp.
ConMed names former Stryker CFO Curt Hartman interim CEO and lowers its outlook for the rest of the year.
Surgical device maker ConMed (NSDQ:CNMD) took a major hit on Wall Street today after announcing some turnover at the top and lowering its financial outlook for the rest of the year.
A Michigan federal judge denies a settlement in the poaching spat between Biomet and Stryker and a pair of ex-Stryker sales reps.
Covidien names Bryan Hanson group president, with oversight of all of the medical device company's businesses.
Stryker Corp. reports 2nd-quarter earnings that meet Wall Street's expectations, despite flat profit growth on 7% sales growth.
Stryker (NYSE:SYK) said today that its 2nd-quarter earnings met expectations on Wall Street, despite flat profit growth, on 7% sales growth.
Stryker Corp. agrees to sell its bone morphogenetic protein-7 assets to Mariel Therapeutics, which plans to investigate BMP-7 as a possible treatment for a variety of conditions.
A federal appeals court overturns Stryker's win over Hill-Rom in a patent spat over hospital bed monitoring systems.
Stryker agrees to acquire the Scandinavian Total Ankle Replacement device from Small Bone Innovations in a deal valued at $375 million.
UPDATED June 30, 2014, with comment from Small Bone Innovations founder.